CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $270,000 | -35.4% | 9,184 | 0.0% | 0.02% | -54.5% |
| Q2 2018 | $418,000 | -13.8% | 9,184 | 0.0% | 0.03% | +13.8% |
| Q1 2018 | $485,000 | -22.4% | 9,184 | 0.0% | 0.03% | -29.3% |
| Q4 2017 | $625,000 | -17.4% | 9,184 | 0.0% | 0.04% | +7.9% |
| Q3 2017 | $757,000 | -12.0% | 9,184 | 0.0% | 0.04% | -17.4% |
| Q2 2017 | $860,000 | +47.0% | 9,184 | 0.0% | 0.05% | +15.0% |
| Q1 2017 | $585,000 | +186.8% | 9,184 | +100.0% | 0.04% | +185.7% |
| Q4 2016 | $204,000 | -51.7% | 4,592 | 0.0% | 0.01% | -54.8% |
| Q3 2015 | $422,000 | -66.3% | 4,592 | -67.7% | 0.03% | -64.4% |
| Q2 2015 | $1,251,000 | +224.9% | 14,235 | +67.6% | 0.09% | +222.2% |
| Q3 2014 | $385,000 | +9.4% | 8,495 | 0.0% | 0.03% | +12.5% |
| Q2 2014 | $352,000 | -40.1% | 8,495 | 0.0% | 0.02% | -36.8% |
| Q1 2014 | $588,000 | -31.5% | 8,495 | -40.3% | 0.04% | -29.6% |
| Q4 2013 | $858,000 | -0.8% | 14,235 | 0.0% | 0.05% | 0.0% |
| Q3 2013 | $865,000 | -9.2% | 14,235 | 0.0% | 0.05% | -3.6% |
| Q2 2013 | $953,000 | – | 14,235 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |